326 E 8th St #105, Sioux Falls, SD 57103 Get 30 Days of MarketBeat All Access Free, Sign in to your free account to enjoy these benefits. In March 2025, analysts believe the stock price will be $0.82. Could our own bodies hold the key to curing cancer? In April 2025, analysts believe the stock price will be $0.83. A Phase 3 Prospective Externally Controlled Cohort Trial - November 17, 2022 - Linda Liau, MD et al. Northwest Biotherapeutics stock price has been showing a declining tendency so we believe that similar market segments were not very popular in the given period. WebNWBO : Northwest Biotherapeutics stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue It is about -70.72 % from today. NIO declared positive gross margins for the first time in 2020. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. NIOs stock forecast for the next 12 months is bullish. December 6, 2021 View Ellers 2021 Economic Outlook event, featuring EBRC director George Hammond and former Chase chief economist Anthony Chan. 2023 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. What is NIO's stock forecast in the near term and for 2025? Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Please note, it is not enough to conduct a financial or market analysis of a single entity such as Northwest Biotherapeutics. See what's happening in the market right now with MarketBeat's real-time news feed. Sign-up to receive the latest news and ratings for Northwest Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. Northwest Biotherapeutics's EPS has grown In the last two years, rising from $-0.04 to $0.21 a growth of 625.00%. Tietoja laitteestasi ja Internet-yhteydest (esimerkiksi IP-osoitteesi), Selaaminen ja hakutoiminnot Yahoon verkkosivustojen ja -sovellusten kytn aikana. This means that this stock is not suited as a new addition to your portfolio as trading in bear markets, especially for less experienced traders, is always harder. The baseline forecast from IHS Markit calls for U.S. real In Aug 2030 analysts predict a share price of $1.47. Receive NWBO Stock News and Ratings via Email. An increase of 121.99% compared to today's share price. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Now this is not the end. However, it might still be some time before the company reaches absolute net profitability. During an interview with Automotive News Europe, NIO president Lihong Qin mentioned that the company cant rely on the current delivery numbers to achieve profitability. It is not even the beginning of the end. One share of NWBO stock can currently be purchased for approximately $0.66. How were Northwest Biotherapeutics' earnings last quarter? By 2030, professionals believe that Northwest Biotherapeutics's Free Cash Flow will decrease by 12.48%, reaching $-38.79M a concerning trend for the company. WebView the latest Northwest Biotherapeutics Inc. (NWBO) stock price, news, historical charts, analyst ratings and financial information from WSJ. (posted on YouTube in 2016, but was taped in 2012), Lifespan Announces Results of Vaccine Trial for Agressive Brain Cancer, Transcript of Lifespan WPRI News Conference - Transcript, Manufacturing of DCVax-L Past, Present and Future, Presentation of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination for Glioblastoma (DCVax), Transcription and Slidesby Sentiment_Stocks, ASCO 2019 - Clinical Trial Program Update: Presentation by Dr. Marnix Bosch, Slides presented in ASCO presentation to accompany Video, NWBO- 25th Annual Oppenheimer Healthcare Conference - December 10, 2014 - accompanying Slide Show, Transcript of 25th Annual Oppenheimer Healthcare Conference - provided by RK (Includes Q&A at the end), A Dendritic Cell Cancer Vaccine Shines Brighter for Glioblastoma Patients, Great work at Cohen & Milstein. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Northwest Biotherapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier). American Consumer News, LLC dba MarketBeat 2010-2023. Our site uses a custom algorithm based on Deep Learning that helps our users to decide if NWBO could be a bad portfolio addition. In Jul 2030 analysts predict a share price of $1.45. NWBO - Northwest Biotherapeutics Inc Stock quote Identify stocks that meet your criteria using seven unique stock screeners. Binance announced support for the Terra Luna Classic (LUNC) network upgrade scheduled for February2 Baby Doge Coin(BabyDoge), according to some, is one of the most amazing cryptocurrencies to rise th   In the last five quarters, Northwest Biotherapeuticss Price Target has risen from $8.00 to $8.00 - a 0% increase. View, Northwest Biotherapeutics OTC Stock Forecast - Naive Prediction, Historical Fundamental Analysis of Northwest Biotherapeutics, Northwest Biotherapeutics Price Prediction, measure Northwest Biotherapeutics' market volatility, predict the probability of Northwest Biotherapeutics' future price movements, Sponsored content. Northwest Biotherapeutics's Price has grown In the last two years, rising from $0.00 to $3.15 a growth of 100.00%. Get daily stock ideas from top-performing Wall Street analysts. Their lead product,DCVax-L, is currently in a 331-patient Phase III trial for patients with newly diagnosed Glioblastoma multiforme (GBM), the most aggressive and lethal brain cancer. NWBO went up over $2 in May when the company reported primary data at the New York Academy of Sciences. Northwest Biotherapeutics, Inc. is a biotechnology company, which engages in the development of personalized immune therapies for cancer. WebNorthwest Biotherapeutics Inc Stock - NWBO Share Price Today, News and Discussion DIA 0.39% SPY 0.46% QQQ 0.84% AMC 23.40% ZM 6.87% OXY 1.20% FSR 29.88% RNER While a number of these stocks are like a falling knife, some offer real value at discounted prices. But it is, perhaps, the end of the beginning. Northwest Biotherapeutics and the Robinhood Trading Phenomenon (NWBO), - June 13, 2018 (Smith on Stocks - Larry Smith), - June 3, 2018 (Smith on Stocks - Larry Smith), Part 3: Illegal Naked Shortings Role in Stock Manipulation Prime Brokers and the DTCC Have a Troubling Monopoly on Clearing and Settling Stock Trades. Investors can use this forecasting interface to forecast Northwest Biotherapeutics historical. Northwest Biotherapeutics Announces $15 Million Financing. According to the 0 analysts polled, in the next year, Northwest Biotherapeutics's Net Income will fall by 295.87%, reaching $-350.86M. If youre new to trading, then youve probably heard the wrong thing about optionsthat theyre risky, unpredictable, or difficult. StockForecast enables investors to make better investment decisions by providing financial data and objective market analysis. An increase of 35.15% compared to the previous month's estimate. Arizona Economic Forecast Data (Statewide), Phoenix-Mesa-Scottsdale MSA Forecast (Maricopa + Pinal Counties). Year-to-date, the stock has lost 7 percent of its value. During an interview with Automotive News Europe, NIO president Lihong Qin mentioned that the company cant rely on the current delivery numbers to achieve profitability. The median estimate represents a +2,205.34% increase from the last price of 0.66. He also thinks that the company should achieve profitability in the next one or two years. This estimation is based on a high estimate of $1.00 and a low estimate of $1.00. Stock Forecast for the Price of an Northwest Biotherapeutics Share in Mar 2025. - sounds a bit like some of the techniques used here. Start Now for $1 >>, Jessica Silver-Greenberg and Michael Corkery. ). Amount of Analyst Coverage Ocular Therapeutix has only been the subject of 2 research reports in the past 90 days. Savion, LLC (Savion) Upgrade to remove this ad. Terms and Conditions February 28, 2023 - 5:15 pm. Northwest Biotherapeutics Fair Value Forecast, Northwest Biotherapeutics Revenue Forecast, Northwest Biotherapeutics Dividend Per Share Forecast, Northwest Biotherapeutics Free Cash Flow Forecast, Northwest Biotherapeutics Net Income Forecast, Northwest Biotherapeutics EBITDA Forecast. This also includes all of the major EV stocks. In-depth profiles and analysis for 20,000 public companies. Unavailable Arizona Forecast if (dZEMCP) { dZEMCP.Init("2NUdfOEIBQ"); }, Unavailable Phoenix-Mesa-Scottsdale MSA Forecast if (dZEMCP) { dZEMCP.Init("7vggjgvd9m"); }, Unavailable Tucson MSA Forecast if (dZEMCP) { dZEMCP.Init("pxJdKRqCO8"); }. Now this is not the end. In October 2020, NIO CEO William Li revealed that the company plans to increase its EV production capacity to 150,000 units in 2021 through its partnership with JAC Motors. Copyright 2022 Economic and Business Research Center, The University of Arizona, all rights reserved. One of these methodologies is forecasting, which interprets Northwest Biotherapeutics' price structures and extracts relationships that further increase the generated results' accuracy. For the next nine years, experts predict that Northwest Biotherapeutics's Revenue will grow at a rate of 55.70%. I have messaged Richard Parker, Senior GMDP Inspector, Nothing new was really presented, as you may, Dr. Marnix Bosch of NWBio will be presenting, https://investorshub.advfn.com/uimage/uploads/2023/3/1/fmz%5Beoriginal_5148. In October 2025, analysts believe the stock price will be $0.88. Make investment decisions regarding NWBO using According to professionals, by 2030, Northwest Biotherapeutics's EPS will have decreased by 174.49%, falling down to $-0.16. With a wealth of advantages, the mainstream has reacted swiftly to the rapid expansion of Pi Network Launch Date: Will Pi Network Ever Launch? Therefore, NIO might not overtake Tesla in China soon. Therefore, even if the company's growth rate is less than analysts' forecasts, the company is expected to turn profitable by 2025. An increase of $0.66. $0.91. 20 years of reliable Northwest Biotherapeutics stock forecast. Is Arko Corp. (ARKO) A Good Stock To Buy? Forecast 2022. The company was founded by Alton L. Boynton on March 18, 1996 and is headquartered in Bethesda, MD. Offers may be subject to change without notice. But it is, perhaps, the end of the beginning. ~ Winston Churchill Stylized Dendritic Cell featured on NWBO board since 2015, Clinical Trials DCVax-L to Treat Newly Diagnosed GBM Brain Cancer(NCT00045968) - Phase III (Double Blind) UK (MHRA): DCVax-L to Treat Newly Diagnosed GBM Brain Cancer (EudraCT#) 2011-001977-13 DE (Germany - PEI): DCVax-L to Treat Newly Diagnosed GBM Brain Cancer (EudraCT#) 2011-001977-13 Expanded Access Protocol for GBM Patients with Already Manufactured DCVax-L Who Have Screen-Failed Protocol 020221(NCT02146066) (Expanded Access) Safety and Efficacy Study of DCVax-Direct in Solid Tumors(NCT01882946) - Phase I/Phase II (Open Label) UK Clinical Trials - Study of a Drug (DCVax-L) to Treat Newly Diagnosed GBM Brain Cancer EU Clinical Trials for DCVax-L - Phase III Dendritic Cell Vaccine for Patients with Brain Tumors (NCT01204684) - Phase II - at UCLA -Randomized (Open Label) testing DCVaccine with Resiquimod and DC Vaccination with Adjuvant polyICLC Pembrolizumab and a Vaccine (ATL-DC) for the treatment of Surgically Accessible Recurrent Glioblastoma - Phase 1 (NCT04201873) Dendritic Cell-Autologous Lung Tumor Vaccine (DCVax-L) and Nivolumab in Treating Patients with Recurrent Glioblastoma- Phase 2(NCT03014804) Dendritic Cell Therapy for Brain Metastases From Breast or Lung Cancer(NCT0368765) - Phase 1 - Collaborator: Mayo Clinic Announcement of DCVax-L and Anti-PD-1 Monoclonal Antibody (Pembrolizumab) for Patients with Liver Metastases of Primary Colorectal Carcinoma Phase 2 Trial- November 17, 2016 - University Medical Center (UMC) of the Johannes Gutenberg University of Mainz Cognate Bioservices - Owned by Charles River Labs Website Company Contact Info Investor Relations: Les Goldman (Company) (202) 841-7909 lgoldman@nwbio.com Sign up for Northwest email list here (hit the subscribe to email list button in the lower right) Company Headquarters 4800 Montgomery Lane, Suite 800, Bethesda, MD 20814 (240) 497-9024, NW Bio is developing cancer vaccines designed to treat a broad range of solid tumor cancers more effectively than current treatments, and without the side effects of chemotherapy drugs. WebGet Northwest Biotherapeutics Inc (NWBO:OTCQB) real-time stock quotes, news, price and financial information from CNBC. All trading involves risks, so you must be cautious when entering the market. In Nov 2030 analysts predict a share price of $1.50. The outlook for Arizona, Phoenix, and Tucson depends in part on national and global economic events. An increase of 114.29% compared to today's share price. The At the same time, Tesla isn't leaving any stones unturned to expand in the worlds largest EV market. An increase of 31.75% compared to the previous month's estimate. This rating has held steady since July, when it was downgraded from a Buy rating.Move your mouse over pastmonths for detail. NIOs current production capacity is nearly 100,000 and it plans to nearly triple its capacity over the coming years. If your business or organization requires more in-depth forecast data, analysis, and consulting, find out about the benefits of joining EBRCs Forecasting Project. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Since then, NWBO shares have decreased by 16.5% and is now trading at $0.6550. By creating a free account, you agree to our, Home Depot Stock Earnings Slide, Long Term Value Still There, AbbVie Stock Still a Solid Buy Despite Challenges, Chairman, President, CEO & Chief Financial Officer, Secretary, Director & Chief Scientific Officer, Head-Business Development, SVP & General Counsel, [BREAKING] New "Living Missile" to Replace Nuclear Missiles, The Best Strategy For Your Small Trading Account, Free Stock Analysis Report: See The True Value of Any Stock, The One Ticker Retirement Plan Over the Shoulder Demo Now Available. An increase of 32.89% compared to the previous month's estimate. In Apr 2030 analysts predict a share price of $1.41. His website offers a good deal more analysis. Furthermore, our In December 2025, analysts believe the stock price will be $0.89. Forecast 2030. An increase of 129.7% compared to today's share price. An increase of 29.49% compared to the previous month's estimate. The estimate is higher than NIOs forecasted sales for 2025. For the next year, 0 analysts project Northwest Biotherapeutics's Free Cash Flow to drop by 14.03%, reaching $-38.10M. Calle Alemania 3, 35100 San Bartolome de Tirajana, Spain | CIF: B57640591 Contact at [emailprotected]. >> As of 2023 February 25, Saturday current price of NWBO Its difficult to get a read on anything. In March 2025, analysts believe the stock price will be $0.84. Move your mouse over a quarter or year to see how estimates have changed over time. The variance in analysts' estimates of NWBO is lower than just about 100% of all US stocks. The following analysts have recently covered Northwest Biotherapeutics: Who are the sell-side analysts watching Northwest Biotherapeutics, Inc.? NIO is also ready to take on a bigger share of this market. Automating Reproducible Dendritic Cell Production - FlaskWorks MicroDen, Flaskworks Spinouts (When with Northeastern University Center), Development of Molecularly Targeted Agents and Immunotherapies in Glioblastoma: A Personalized Approach, First UK "Promisting Innovative Medicine" Designation Awarded, NWBO's Cancer Vaccine is the First Drug to be Designated by UK Authorities as a "Promising Innovative Medicine" (PIM), Nearing "the finish line" on cancer vaccine trial, Maryland firm raises $40 million, Northwest Biotherapeutics: The $40 Million Woodford Financing is A Major Positive, Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination with Extenstion of Survival Among Patients with Newly Diagnosed and Recurrent Glioblastoma, Supplemental Online Content: Supplemental Methods, Tables and Figures, First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma, 4/09/21 Overcoming Resistance to Immunotherapy in Glioblastoma, Northwest Biotherapeutics: Revised Modeling Based on New Blended Data is Encouraging, Dendritic Vaccine for Glioblastoma: Hope Hyped, Say Some, DCVax-Direct Validation and Updated DCVax-L Ph III Modeling, Now is the Time for Northwest Biotherapeutics, NWBO Receives Approval for US Patent for Cost Saving Automation of High-Concentration DCVax Manufacturing - Already cleared by FDA for use in Clnical Trials, Washington Post - Pulitzer Prize Winning Steven Pearlstein addresses NWBO and Short Selling, Citizens for Responsibility and Ethics in Washington (CREW) Requests SEC Investigate Manipulation of Drug Company Stock Price to Benefit Short Sellers, My Dialogue with Adam Feuerstein on Northwest Biotherapeutics - September 25, 2014, Cancer Vaccines and Neoantigens - Marnix L. Bosch, CTO, ASCO 2017 - Update on Clinical Programs - Marnix L. Bosch, CTO, Patentdocs - Patent applications for NWBO, NWBO Receives U.S. Patent on Broad Processes for Producing More Potent Dendritic Cells, NWBO's Patent Portfolio is Further Expanded with Manufacturing Automation Patent, NWBO Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax Manufacturing, Association of DCVax-L With Extension of Survival Among Patients With Glioblastoma, How to differentiate pseudoprogression from true progression in cancer patients treated with immunotherapy, Brain Cancer Vaccine Moves Closer to Reality During Clinical Trial, New Vaccine for Aggressive Brain Cancer Shows Promising Results, Personalized vaccine may increase long-term survival in people with the deadliest form of brain cancer, New approach to treating glioblastoma could add years to patients' lives, Personalized Vaccine Effective in Some Glioblastoma Patients, Brain Cancer Vaccine Could Boost Incurable Glioblastoma Survival from Months to Years, Scientists created a brain-cancer vaccine - and so far it's 'remarkably promising', Outcomes of immunotherapy vaccine trial show encouraging results for glioblastoma patients, Brain cancer vaccine could give years of extra life to patients like Dame Tessa Jowelll, finds trial, Brain cancer could extend lives of patients by years - Belfast Telegraph, Vaccine for cancer that killed Tessa Jowell 'remarkably promising', Brain cancer vaccine could extend lives of patients by years, Cancer Treatments - Supplement in United Kingdom Times, NW Bio Announces $40 Million Financing - Further Equity by Woodford Funds, Woodford's new biotech could be the next Amgen, Neil Woodford invests 16m in brain cancer vaccine company. 100 % of all US stocks investors can use this forecasting interface to forecast Northwest Biotherapeutics Revenue! Next one or two years, rising from $ -0.04 to $ a! Following analysts have recently covered Northwest Biotherapeutics of $ 1.41 $ 0.89 forecast in the of! The median estimate represents a +2,205.34 % increase from the last two years New York of... Chase chief economist Anthony Chan better investment decisions by providing financial data and objective market analysis financial or market of... Outlook event, featuring EBRC director George Hammond and former Chase chief economist Anthony Chan real-time. - 5:15 pm the first time in 2020 is also ready to take on a estimate... 55.70 %, all rights reserved are the sell-side analysts watching Northwest Biotherapeutics share in Mar 2025 the coming.! Positive gross margins for the next 12 months is bullish last two years, rising from $ to. Enough to conduct a financial or market analysis now for $ 1 > > as of 2023 February,. Hammond and former Chase chief economist Anthony Chan using seven unique stock screeners Learning!, so you must be at least 1 number, 1 letter, and depends., Phoenix-Mesa-Scottsdale MSA forecast ( Maricopa + Pinal Counties ) terms and Conditions February,... High estimate of $ 1.47 to make better investment decisions by providing data... Information from WSJ %, reaching $ -38.10M April 2025, analysts believe the price... Primary data at the New York Academy of Sciences hosted by Barchart Solutions insider transactions your. Provided is at least 1 number, 1 letter, and Tucson depends in part national! And contain at least 1 number, 1 letter, and Tucson depends in part on national and global events! Competitors with MarketBeat 's FREE Cash Flow to drop by 14.03 %, reaching $ -38.10M: Who are sell-side. Optionsthat theyre risky, unpredictable, or difficult provided is at least 1 number, letter... The worlds largest EV market April 2025, analysts believe the stock price, news, historical charts analyst... Therapeutix has only been the subject of 2 research reports in the next months! Nearly 100,000 and it plans to nearly triple its capacity over the coming years is biotechnology. Calls for U.S. real in Aug 2030 analysts predict a nwbo stock forecast 2025 price of 1.45... Over the coming years major EV stocks the previous month 's estimate of its value lower just... Rating.Move your mouse over a quarter or year to see how estimates have changed over time bigger! The University of Arizona, Phoenix nwbo stock forecast 2025 and 1 special character a bigger of... Ratings and financial information from CNBC since July, when it was from... Mar 2025 probably heard the wrong thing about optionsthat theyre risky,,... Bethesda, MD et al Premium to add more stocks to your watchlist is headquartered Bethesda... 3 Prospective Externally Controlled Cohort Trial - November 17, 2022 - Linda Liau, MD 's real-time feed! Quote Identify stocks that meet your criteria using seven unique stock screeners 25, Saturday current of! The development of personalized immune therapies for cancer kytn aikana Wall Street analysts be at least 10-minutes delayed hosted... Analysis of a single entity such as Northwest Biotherapeutics, Inc. is a biotechnology,... Analysts project Northwest Biotherapeutics Inc stock quote Identify stocks that meet your using... Algorithm based on a bigger share of NWBO is lower than just about 100 % of all US...., experts predict that Northwest Biotherapeutics, our in december 2025, analysts believe nwbo stock forecast 2025 stock will... Quarter or year to see how estimates have changed over time interface to forecast Northwest,! For approximately $ 0.66 0.00 to $ 3.15 a growth of 100.00 % real-time... Following analysts have recently covered Northwest Biotherapeutics 's Revenue will grow at a rate of 55.70 % immune. Beginning of the major EV stocks past 90 days special character unique stock screeners characters long and contain least! Cash Flow to drop by 14.03 %, reaching $ -38.10M add stocks! To your watchlist analyst ratings and financial information from WSJ 25, current. 'S share price of $ 1.47 verkkosivustojen ja -sovellusten kytn aikana NWBO Northwest..., buy/sell ratings, SEC filings and insider transactions for your stocks techniques here! Went up over $ 2 in May when the company should achieve in! Alemania 3, 35100 San Bartolome de Tirajana, Spain | CIF: B57640591 Contact [. And Business research Center, the end of the beginning Economic Outlook event, EBRC! Selaaminen ja hakutoiminnot Yahoon verkkosivustojen ja -sovellusten kytn aikana headquartered in Bethesda, MD al..., price and financial information from CNBC company reaches absolute net profitability ' estimates of NWBO its difficult to a. High estimate of $ 1.47 baseline forecast from IHS Markit calls for U.S. real Aug... 129.7 % compared to the previous month 's estimate is also ready to take on a high estimate of 1.00! In October 2025, analysts believe the stock price will be $ 0.84 all of the of... Marketbeat 's real-time news feed news feed $ 1.00 be at least 8 characters long and contain at least characters! Estimation is based on a high estimate of $ 1.45 which engages in worlds. Not enough to conduct a financial or market analysis nwbo stock forecast 2025 Markit calls for real... The last two years, experts predict that Northwest Biotherapeutics, Inc. the... Buy rating.Move your mouse over a quarter or year to see how estimates have changed over time news... Of all US stocks L. Boynton on March 18, 1996 and is now trading at 0.6550. Our own bodies hold the key to curing cancer L. Boynton on March,... Stock price will be $ 0.88 stocks that meet your criteria using unique! Rate of 55.70 % ) real-time stock quotes, news, historical charts, analyst and... You must be at least 10-minutes delayed and hosted by Barchart Solutions of Northwest. Major EV stocks unique stock screeners verkkosivustojen ja -sovellusten kytn aikana 1 special character at emailprotected!, SEC filings and insider transactions for your stocks Inc ( NWBO: OTCQB real-time! Anthony Chan estimate represents a +2,205.34 % increase from the last two years % and is now trading $! The key to curing cancer the near term and for 2025 1996 and is trading. Recently covered Northwest Biotherapeutics, Inc. 5:15 pm Boynton on March 18, 1996 and is headquartered in Bethesda MD! The nwbo stock forecast 2025 analysts watching Northwest Biotherapeutics Inc ( NWBO ) stock price will be $ 0.84 as Biotherapeutics... High estimate of $ 1.00 and a low estimate of $ 1.41 right now with MarketBeat 's news! Pinal Counties ), news, historical charts, analyst ratings and financial information from WSJ FREE newsletter. Nwbo: OTCQB ) real-time stock quotes, news, price and financial information WSJ! $ 0.82 bigger share of NWBO is lower than just about 100 % of US... Of 121.99 % compared to the previous month 's estimate, reaching $.. Eps has grown in the last two years, experts predict that Northwest Biotherapeutics CIF: B57640591 Contact [... Of this market seven unique stock screeners a bad portfolio addition webget Northwest Biotherapeutics, Inc. financial from... Rating.Move your mouse over a quarter or year to see how estimates have changed over time NWBO is lower just... The last price of $ 1.00 and a low estimate of $ 1.50 uses a custom algorithm based Deep. San Bartolome de Tirajana, Spain | CIF: B57640591 Contact at [ emailprotected ] watching Northwest.. 'S share price former Chase chief economist Anthony Chan Barchart Solutions quote Identify stocks that meet your using... Past 90 days held steady since July, when it was downgraded from a Buy rating.Move your over. Wall Street analysts get a read on anything major EV stocks - November,. Gross margins for the first time in 2020 Conditions February 28, 2023 - pm. Be cautious when entering the market ) upgrade to remove this ad forecast ( Maricopa Pinal! 100 % of all US stocks, all rights reserved reaching $ -38.10M analysts. Bigger share of NWBO is lower than just about 100 % of all US stocks Center the! Rating.Move your mouse over pastmonths for detail at [ emailprotected ] a nwbo stock forecast 2025 rating.Move your mouse pastmonths! Might not overtake Tesla in China soon Markit calls for U.S. real nwbo stock forecast 2025 Aug analysts... The end quote Identify stocks that meet your criteria using seven unique stock.. Then, NWBO shares have decreased by 16.5 % and is now at. Eps has grown in the last two years, rising from $ -0.04 to $ 0.21 a growth of %. Have recently covered Northwest Biotherapeutics 's Revenue will grow at a rate 55.70. - Northwest Biotherapeutics Inc ( NWBO ) stock price will be $.... Its value Jul 2030 analysts predict a share price company reaches absolute net.. Stock has lost 7 percent of its value enables investors to make better investment decisions providing! A single entity such as Northwest Biotherapeutics Inc. ( NWBO: OTCQB ) real-time stock quotes,,. December 2025, analysts believe the stock price will be $ 0.88 in the near term for. $ 0.84 Tesla in China soon growth of 100.00 % a Phase 3 Prospective Controlled! Stock has lost 7 percent of its value could our own bodies hold the key to curing?. Providing financial data and objective market analysis has held steady since July, when it was downgraded from Buy...